These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

726 related items for PubMed ID: 24951323

  • 21. A new prognostic model for cancer-specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factors.
    Todenhöfer T, Renninger M, Schwentner C, Stenzl A, Gakis G.
    BJU Int; 2012 Dec; 110(11 Pt B):E533-40. PubMed ID: 22578156
    [Abstract] [Full Text] [Related]

  • 22. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
    Zhang J, Zhou X, Ding H, Wang L, Liu S, Liu Y, Chen Z.
    BMC Urol; 2020 Mar 19; 20(1):31. PubMed ID: 32192483
    [Abstract] [Full Text] [Related]

  • 23. Radical cystectomy in a Dutch University hospital: long-term outcomes and prognostic factors in a homogeneous surgery-only series.
    Bruins HM, Arends TJ, Pelkman M, Hulsbergen-van de Kaa CA, van der Heijden AG, Witjes JA.
    Clin Genitourin Cancer; 2014 Jun 19; 12(3):190-5. PubMed ID: 24332508
    [Abstract] [Full Text] [Related]

  • 24. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    Orré M, Latorzeff I, Fléchon A, Roubaud G, Brouste V, Gaston R, Piéchaud T, Richaud P, Chapet O, Sargos P.
    PLoS One; 2017 Jun 19; 12(4):e0174978. PubMed ID: 28384195
    [Abstract] [Full Text] [Related]

  • 25. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Buisan O, Orsola A, Areal J, Font A, Oliveira M, Martinez R, Ibarz L.
    Clin Genitourin Cancer; 2017 Feb 19; 15(1):145-151.e2. PubMed ID: 27364982
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
    Solsona E, Climent MA, Iborra I, Collado A, Rubio J, Ricós JV, Casanova J, Calatrava A, Monrós JL.
    Eur Urol; 2009 Apr 19; 55(4):911-9. PubMed ID: 18722046
    [Abstract] [Full Text] [Related]

  • 29. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D, Gong YQ, Hao H, He ZS, Li XS, Zhang CJ, Zhou LQ.
    BMC Cancer; 2017 Jun 02; 17(1):391. PubMed ID: 28578683
    [Abstract] [Full Text] [Related]

  • 30. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR, Boorjian SA, Frank I, Tarrell RF, Thapa P, Karnes RJ, Thompson RH, Tollefson MK.
    Eur Urol; 2014 Dec 02; 66(6):1157-64. PubMed ID: 24630414
    [Abstract] [Full Text] [Related]

  • 31. Favourable outcomes of patients with clinical stage T3N0M0 bladder cancer treated with induction low-dose chemo-radiotherapy plus partial or radical cystectomy vs immediate radical cystectomy: a single-institutional retrospective comparative study.
    Koga F, Kihara K, Fujii Y, Yoshida S, Saito K, Masuda H, Kageyama Y, Kawakami S.
    BJU Int; 2009 Jul 02; 104(2):189-94. PubMed ID: 19154452
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
    Gandaglia G, Popa I, Abdollah F, Schiffmann J, Shariat SF, Briganti A, Montorsi F, Trinh QD, Karakiewicz PI, Sun M.
    Eur Urol; 2014 Sep 02; 66(3):561-8. PubMed ID: 24486024
    [Abstract] [Full Text] [Related]

  • 35. Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.
    Kitagawa Y, Izumi K, Miwa S, Kadono Y, Konaka H, Mizokami A, Namiki M.
    Anticancer Res; 2013 Oct 02; 33(10):4497-503. PubMed ID: 24123021
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov 02; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 38. A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer.
    El-Monim HA, El-Baradie MM, Younis A, Ragab Y, Labib A, El-Attar I.
    Urol Oncol; 2013 Apr 02; 31(3):359-65. PubMed ID: 21353794
    [Abstract] [Full Text] [Related]

  • 39. Pathology-based risk stratification of muscle-invasive bladder cancer patients undergoing cystectomy for persistent disease after induction chemoradiotherapy in bladder-sparing approaches.
    Koga F, Fujii Y, Masuda H, Numao N, Yokoyama M, Ishioka J, Saito K, Kawakami S, Kihara K.
    BJU Int; 2012 Sep 02; 110(6 Pt B):E203-8. PubMed ID: 22289431
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.